Bolt Biotherapeutics, Inc. Liquidation Value
BOLT
Other
Cash & Equivalents
$11.70M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $11.70M
Total Obligations: -$31.39M
$-19.69M
Per share: $-10.25
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $11.70M
AR: $0
Total Obligations: -$31.39M
$-19.69M
Per share: $-10.25
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $11.70M
AR: $0
Inventory: $0
Total Obligations: -$31.39M
$-19.69M
Per share: $-10.25
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-19.69M | $-10.25 |
| Liquid Liquidation Value | $-19.69M | $-10.25 |
| Operating Liquidation Value | $-19.69M | $-10.25 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $11.70M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $8.44M |
| Long-term Debt | N/A |
| Op. Lease Liability | $22.96M |
| Finance Lease | N/A |
| Shares Outstanding | 1.9M |
Explore all 174 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $11.70M | N/A | N/A | $1.44M | $8.44M | N/A | $22.96M | N/A |
| 2025-09-30 | $17.75M | N/A | N/A | $1.52M | $9.97M | N/A | $23.59M | N/A |
| 2025-06-30 | $9.60M | N/A | N/A | $1.85M | $12.31M | N/A | $24.18M | N/A |
| 2025-03-31 | $8.39M | N/A | N/A | $1.53M | $13.56M | N/A | $24.71M | N/A |
| 2024-12-31 | $7.21M | N/A | N/A | $1.51M | $15.86M | N/A | $25.21M | N/A |
| 2024-09-30 | $9.37M | N/A | N/A | $1.48M | $18.08M | N/A | $18.18M | N/A |
| 2024-06-30 | $6.20M | N/A | N/A | $2.63M | $17.90M | N/A | $18.89M | N/A |
| 2024-03-31 | $4.26M | N/A | N/A | $2.22M | $16.72M | N/A | $19.57M | N/A |
▼ Community Notes